StonvexLoading…
StonvexStonvexStonvexCore line items from RILY's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $788.99M | $985.98M | $1.11B | $825.55M |
Operating Income | $75.58M | $-497.55M | $96.05M | $29.86M |
Net Income | $307.42M | $-764.27M | $-99.91M | $-159.83M |
EPS (Diluted) | $9.80 | $-25.46 | $-3.69 | $-5.95 |
Total Assets | $1.71B | $1.78B | $6.08B | $6.11B |
Total Liabilities | $1.83B | $2.24B | $5.72B | $5.43B |
Cash & Equivalents | $226.60M | $146.85M | $222.69M | $268.62M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 30.60M | 30.50M | 29.94M | 28.52M |